• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药耐药肺结核患者辅助肺切除术后并发症的危险因素分析:一项多机构研究。

Risk factor analysis of postoperative complications after adjunctive pulmonary resection in patients with multidrug-resistant tuberculosis: A multi-institutional study.

机构信息

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Chung University, Tainan, Taiwan.

Chest Hospital, Ministry of Health and Welfare, Tainan, Taiwan.

出版信息

J Microbiol Immunol Infect. 2023 Oct;56(5):1064-1072. doi: 10.1016/j.jmii.2023.07.006. Epub 2023 Jul 28.

DOI:10.1016/j.jmii.2023.07.006
PMID:37586914
Abstract

BACKGROUND AND OBJECTIVE

Multidrug-resistant tuberculosis (MDR-TB) requires extended treatment with regimens with multiple side effects, resulting in high treatment failure rates. Adjunctive lung resection combined with anti-tubercular agents improves outcomes. However, few studies have evaluated the potential harm from surgery and determined the optimal conditions for surgery. We aimed to analyze perioperative conditions to assess risk factors for postoperative complications in a multi-institutional setting.

METHODS

This retrospective study included 44 patients with MDR-TB who underwent adjunctive lung resection at three management groups of the Taiwan MDR-TB consortium between January 2007 and December 2020. Demographic data, clinical characteristics, radiological findings, sputum culture status before surgery, primary or acquired drug resistance, surgical procedure, complications, and treatment outcomes were collected and analyzed. Multivariate logistic regression was used to identify risk factors for postoperative complications.

RESULTS

Twenty-seven patients (61.4%) underwent lung resection using video-assisted thoracic surgery (VATS). The overall surgical complication rate was 20.5%, and the surgical mortality rate was 9.1%. Postsurgical hemothorax was the most common complication (11.4%). According to the univariate analysis, hilum involvement in images, positive preoperative sputum culture, and thoracotomy approach were unfavorable factors. VATS approach [adjusted OR, 0.088 (95% CI, 0.008-0.999)] was the only favorable factor identified by multivariate analysis.

CONCLUSION

The minimally invasive approach is a growing trend, and lobectomies and sublobar resections were the main procedures for MDR-TB. The VATS approach significantly reduced the surgical complication rate. Postsurgical hemothorax was noteworthy, and meticulous hemostasis of the chest wall and residual lung surface is critical for successful resections.

摘要

背景与目的

耐多药结核病(MDR-TB)需要采用具有多种副作用的方案进行长期治疗,导致治疗失败率较高。辅助性肺切除术联合抗结核药物可改善治疗效果。然而,很少有研究评估手术带来的潜在危害,并确定手术的最佳条件。我们旨在分析围手术期情况,以评估多机构环境下术后并发症的危险因素。

方法

本回顾性研究纳入了 2007 年 1 月至 2020 年 12 月期间,台湾耐多药结核病联合会的三个管理组中 44 例接受辅助性肺切除术的 MDR-TB 患者。收集并分析了人口统计学数据、临床特征、影像学发现、手术前痰培养状况、原发性或获得性药物耐药性、手术方式、并发症和治疗结果。采用多变量逻辑回归分析确定术后并发症的危险因素。

结果

27 例患者(61.4%)采用电视辅助胸腔镜手术(VATS)进行肺切除术。总的手术并发症发生率为 20.5%,手术死亡率为 9.1%。术后血胸是最常见的并发症(11.4%)。根据单因素分析,影像学上的肺门受累、术前痰培养阳性和开胸手术方式是不利因素。VATS 方法[调整后的优势比(OR),0.088(95%可信区间,0.008-0.999)]是多变量分析中唯一确定的有利因素。

结论

微创手术是一种不断发展的趋势,肺叶切除术和亚肺叶切除术是 MDR-TB 的主要手术方式。VATS 方法显著降低了手术并发症发生率。术后血胸值得关注,仔细止血胸壁和残肺表面对于成功切除至关重要。

相似文献

1
Risk factor analysis of postoperative complications after adjunctive pulmonary resection in patients with multidrug-resistant tuberculosis: A multi-institutional study.多药耐药肺结核患者辅助肺切除术后并发症的危险因素分析:一项多机构研究。
J Microbiol Immunol Infect. 2023 Oct;56(5):1064-1072. doi: 10.1016/j.jmii.2023.07.006. Epub 2023 Jul 28.
2
Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis.外科治疗耐多药和广泛耐药结核病。
Ann Thorac Surg. 2010 May;89(5):1597-602. doi: 10.1016/j.athoracsur.2010.02.020.
3
Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.多药和广泛耐药结核病患者手术治疗的良好结局。
Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.
4
Surgical treatment to increase the success rate of multidrug-resistant tuberculosis.外科治疗提高耐多药结核病的成功率。
Eur J Cardiothorac Surg. 2012 Jul;42(1):e9-12. doi: 10.1093/ejcts/ezs215. Epub 2012 Apr 24.
5
Pulmonary resection in the treatment of 43 patients with well-localized, cavitary pulmonary multidrug-resistant tuberculosis in Shanghai.上海43例局限性空洞型耐多药肺结核患者的肺切除术治疗
Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):455-9. doi: 10.1093/icvts/ivt251. Epub 2013 Jun 7.
6
Pulmonary resection for multidrug-resistant tuberculosis: the Israeli experience (1998-2011).耐多药肺结核的肺切除术:以色列的经验(1998 - 2011年)
Isr Med Assoc J. 2012 Dec;14(12):733-6.
7
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis.手术作为耐多药结核病的辅助治疗:一项个体患者数据荟萃分析。
Clin Infect Dis. 2016 Apr 1;62(7):887-895. doi: 10.1093/cid/ciw002. Epub 2016 Jan 12.
8
Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis.手术增加了耐多药肺结核的治愈几率。
Eur J Cardiothorac Surg. 1999 Aug;16(2):187-93. doi: 10.1016/s1010-7940(99)00158-x.
9
Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series.肺切除术治疗耐多药结核病:病例系列
Medicine (Baltimore). 2017 Dec;96(50):e9109. doi: 10.1097/MD.0000000000009109.
10
A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis.一项针对49例耐多药肺结核患者肺切除术结局的回顾性研究。
Int J Tuberc Lung Dis. 2002 Feb;6(2):143-9.